Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Athira Pharma Inc
(NQ:
ATHA
)
3.110
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Athira Pharma Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
ATHIRA DEADLINE ALERT
July 26, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs, And More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefited from the optimism that was set in motion by the solid start to the pharma reporting...
Via
Talk Markets
Exposures
Product Safety
ATHIRA SHAREHOLDER ALERT
July 24, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
ATHIRA DEADLINE ALERT
July 23, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Exposures
Product Safety
ATHIRA UPDATE
July 22, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
ATHIRA CLASS ACTION REMINDER
July 21, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
ATHIRA SHAREHOLDER NOTICE
July 20, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
ATHA DEADLINE: Investors With Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action Lawsuit
July 20, 2021
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
ATHIRA INVESTORS: August 24, 2021 Filing Deadline in Class Action – Contact Lieff Cabraser
July 20, 2021
From
Lieff Cabraser Heimann & Bernstein, LLP
Via
Business Wire
ATHIRA SHAREHOLDER ALERT
July 19, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
ATHIRA DEADLINE ALERT
July 18, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
ATHIRA UPDATE
July 17, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
July 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...
Via
Benzinga
ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action – Contact Lieff Cabraser
July 17, 2021
From
Lieff Cabraser Heimann & Bernstein, LLP
Via
Business Wire
ATHIRA CLASS ACTION REMINDER
July 16, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That Class Action Lawsuits Have Been Filed Against Athira Pharma, Inc. and Encourages Investors to Contact the Firm Before August 24, 2021
July 16, 2021
From
Kirby McInerney LLP
Via
Business Wire
ATHIRA SHAREHOLDER NOTICE
July 15, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
ATHA INVESTOR ALERT: Investors With Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action Lawsuit
July 14, 2021
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
ATHIRA SHAREHOLDER ALERT
July 13, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
ATHIRA DEADLINE ALERT
July 12, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Athira Pharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ATHA
July 10, 2021
From
The Rosen Law Firm, P.A.
Via
Business Wire
ATHIRA CLASS ACTION REMINDER
July 09, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
SHAREHOLDER ALERT: Robbins LLP Announces that Athira Pharma, Inc. (ATHA) is Being Sued for Misleading Shareholders
July 09, 2021
From
Robbins LLP
Via
Business Wire
ATHIRA SHAREHOLDER NOTICE
July 08, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
ATHIRA PHARMA SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Athira Pharma, Inc. - ATHA
July 08, 2021
From
Kahn Swick & Foti, LLC
Via
Business Wire
ATHIRA SHAREHOLDER ALERT
July 07, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
NASDAQ:ATHA Investor Notice: Lawsuit Alleges Securities Laws Violations by Athira Pharma, Inc.
July 07, 2021
San Diego, CA -- (SBWIRE) -- 07/07/2021 -- An investor, who purchased NASDAQ:ATHA shares, filed a lawsuit over alleged violations of Federal Securities Laws by Athira Pharma, Inc..
Via
SBWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
ATHIRA DEADLINE ALERT
July 06, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
ATHA Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Athira Pharma, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
July 06, 2021
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.